Artificial skin, dressing materials and novel
drug delivery systems Part 3
Novel
systems of drug delivery.
Role
of bioadhesive polymer systems in enhancing buccal absorption.
Introduction
Even in the present times, it is a tragic statement of fact
that for animals, a significant percentage of veterinary
treatment protocols involve the delivery of medications
via injections. Injections by their very nature, irrespective
of their route of delivery, whether intramuscular, intravenous,
or subcutaneous are inevitably associated with some degree
of pain. Most veterinary practitioners perhaps fondly wish
for the day when they could have a painless system of drug
delivery.
Transmucosal
route
Transmucosal routes of drug delivery are a practitioner's
dream while at the same time being a pharmacologist's toughest
problem. Some difficult problems in transmucosal routes
of drug delivery appear to be in reaching effective concentrations
of the drugs in specific tissues. Among the various different
transmucosal sites where drugs may be deposited, the mucosa
of the oral cavity offers some interesting advantages.
The
nasal, rectal, vaginal and ocular route of drug delivery
appear to have some distinct disadvantages in that it may
be difficult to circumvent the effect of local drug irritation
caused at these sites. Once the irritation or sensitization
to allergens occurs, irreversible damage to the mucosal
lining may be caused. Therefore, great care needs to be
exercised while developing a safe and effective vehicle
for effective drug delivery.
Oral
mucosa
Unique features of the oral mucosa that can hasten absorption
of molecules includes the abundant vascularization, rapid
recovery time after exposure to stress and the near complete
absence of Langerhans cells. The absence of Langerhans cells
is especially significant because, this can make the oral
mucosa relatively tolerant to potential allergens. Another
very significant advantage of using the oral transmucosal
route for drug delivery is that this route can effectively
bypass the first pass and thus avoid the pre-systemic elimination
seen with the gastrointestinal tract.
Three
main sites in the oral cavity where drug delivery can be
effected are:
-
sublingual - lining the floor of the mouth
-
buccal
- lining the cheeks (buccal mucosa)
-
oral
cavity where direct delivery can be effected
The epithelium
of the buccal mucosa is about 40-50 cell layers thick, while
the sublingual epithelium has a slightly lesser number of
cells. It is estimated that the permeability of the buccal
mucosa is 4-4000 times greater than that of the skin .
Mucus
Mucus serves as an effective delivery vehicle by acting as
a lubricant allowing cells to move relative to one another.
Along the same lines, the mucus is also believed to play a
role in bioadhesion of mucoadhesive drug delivery systems.
At physiological pH, the mucus network carries a negative
charge (due to the sialic acid and sulfate residues) which
may play a role in mucoadhesion. At this pH mucus can form
a strongly cohesive gel structure that will bind to the epithelial
cell surface as a gelatinous layer.
Saliva
Another feature of the environment of the oral cavity is the
presence of saliva produced by the salivary glands. Saliva
protects all fluid tissues of the oral cavity. It protects
the soft tissues from abrasion by rough materials and from
chemicals. A main reason behind the selection of hydrophilic
polymeric matrices as vehicles for oral transmucosal drug
delivery systems is the water rich environment of the oral
cavity.
Even
though the sublingual mucosa is relatively more permeable
than the buccal mucosa, it is not suitable for an oral transmucosal
delivery system. The sublingual region does not have the rich
density of smooth muscle tissue fibers or immobile mucosa,
that other regions of the oral cavity have. A constant flowing
down of saliva within the oral cavity makes it very difficult
for drugs to be retained for a significant amount of time
in order to facilitate absorption in this site. The buccal
mucosa is more suited for sustained delivery applications,
delivery of less permeable molecules, and even peptide drugs.
Some
oral mucosal permeation enhancers
- Aprotinin
- Azone
- Benzalkonium
chloride
- Cetylpyridinium
chloride
- Cethylammonium
bromide
- Cyclodextrin
- Dextran
sulfate
- Lauric
acid
- Propylene
glycol,
- Lysophosphatidylcholine
- Menthol
- Methoxysalicylate
- Methyloleate
- Oleic
acid
- Phosphatidylcholine
- Polyoxyethylene
- Polysorbate
80
- Sodium
EDTA
- Sodium
glycocholate
- Sodium
glycodeoxycholate
- Sodium
lauryl sulfate
- Sodium
salicylate
- Sodium
taurocholate
- Sodium
taurodeoxycholate
- Sulfoxides
and vrious alkyl glycosides
- Xanthum
gum
- Locust
bean gum
- Chitosan
- HPC
- CMC
- Pectin
- Xantham
gum
- Hyaluronic
acid
- Benzyl
esters
- Polycarbophil
Buccal
Drug Delivery Systems
Polymers which can adhere to either hard or soft tissue have
been used for many years in surgery and dentistry. Polymers
from many diverse families have been investigated for their
potential use as mucoadhesives. These include synthetic polymers
such as monomeric acyanoacrylate, polyacrylic acid, hydroxypropyl
methylcellulose, and poly methacrylate derivatives as well
as naturally occurring polymers such as hyaluronic acid and
chitosan . Research on the role of other synthetic polymers
such as polyurethanes, epoxy resins, polystyrene, and natural-product
cement have also been extensively explored.
Hydrogels
Hydrogels are hydrophilic matrices that absorb water when
placed in an aqueous media. They are structured in such a
manner that the crosslinking fibers present in their matrix
effectively prevent them from being dissolved and thus help
them in retaining water. When drugs are loaded into these
hydrogels, as water is absorbed into the matrix, chain relaxation
occurs and drug molecules are released through the spaces
or channels within the hydrogel network. Natural gums and
cellulose derivatives also form part of the family of hydrogels.
Hydrogels as a source of adhesive preparation for transmucosal
drug delivery is an emerging area of importance.
Emerging
areas of drug delivery - gene therapy and ultrasound
Other emerging areas of interest include the development of
novel drug delivery systems using ultrasound and laser. Gene
therapy hopefully will share the same degree of relevance
in companion animal and large animal medicine, that it currently
enjoys among it's human practitioners.
Conclusion
The search for improved methods of drug delivery continues
to remain the focus of attention in pharamcological research
endeavours. Improved methods of drug release through transmucosal
and transdermal methods would be of great significance in
veterinary medicine, as by such routes, the pain factor in
drug delivery associated with parenteral routes of drug administration
can be totally eleminated.
References
|